| Teresa Anne Williams, DNP, APRN, AG ACNP | |
|
1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 | |
| (808) 433-2045 | |
| Not Available |
| Full Name | Teresa Anne Williams |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 1 Jarrett White Rd, Tripler Army Medical Center, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033763156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 11003090 (Florida) | Primary |
| Entity Name | Baptist Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376779892 PECOS PAC ID: 9638215734 Enrollment ID: O20091002000436 |
News Archive
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
According to a new national surveillance study released this week, over half of the pregnant women admitted to a hospital in the United Kingdom with COVID-19 are either black or belong to other ethnic minority groups.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced the launch of the OptiDDITM Suite, a novel assay panel that assesses the most clinically significant transporter-related drug-drug interactions (DDIs), as identified by the International Transporter Consortium (ITC) in its report "Membrane Transporters in Drug Development" (Nature Reviews-Drug Discovery, March 2010).
Babies born at just 22 to 24 weeks of pregnancy continue to have sobering outlooks - only about 1 in 3 survive.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Teresa Anne Williams, DNP, APRN, AG ACNP 1717 N E St, Ste 331, Pensacola, FL 32501-6335 Ph: (850) 484-6500 | Teresa Anne Williams, DNP, APRN, AG ACNP 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 Ph: (808) 433-2045 |
News Archive
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
According to a new national surveillance study released this week, over half of the pregnant women admitted to a hospital in the United Kingdom with COVID-19 are either black or belong to other ethnic minority groups.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced the launch of the OptiDDITM Suite, a novel assay panel that assesses the most clinically significant transporter-related drug-drug interactions (DDIs), as identified by the International Transporter Consortium (ITC) in its report "Membrane Transporters in Drug Development" (Nature Reviews-Drug Discovery, March 2010).
Babies born at just 22 to 24 weeks of pregnancy continue to have sobering outlooks - only about 1 in 3 survive.
› Verified 4 days ago
Dr. Eileen M. Gawrys, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-8116 Fax: 808-433-8632 | |
Mrs. Jaclyn Marie Griffin, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-3474 Fax: 808-433-2174 | |
Jeong J Kim, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 253-433-5420 | |
Deidamia Adelina Monfort, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-2040 | |
Dee R Kawamura, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-6933 Fax: 808-433-2187 | |
Kathlyn Dino, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 310-872-3560 |